1. World Health Organization(2017).A study on the public health and socioeconomic impact of substandard and falsified medical products. Geneva Switzerland.http://www.who.int/medicines/regulation/ssffc/publications/Layout‐SEstudy‐WEB.pdf?ua=1(accessed 15 July 2020). Licence: CC BY‐NC‐SA 3.0 IGO.
2. World Health Organization(2017).WHO global surveillance and monitoring system for substandard and falsified medical products. Geneva Switzerland. Licence: CC BY‐NC‐SA 3.0 IGO.
3. OECD (Organisation for Economic Co‐operation and Development)(1998).The economic impact of counterfeiting. Paris France.https://www.oecd.org/sti/ind/2090589.pdf(accessed 20 October 2020).
4. Appendix 3 to Annex(2017).World Health Assembly document A70/23.
5. PWC(2012).From vision to decision: Pharma 2020.https://www.pwc.com/gx/en/pharma‐life‐sciences/pharma2020/assets/pwc‐pharma‐success‐strategies.pdf(14 February 2021)